News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2021 Caitlin E. Cox May 03, 2021
News Daily News CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA Shelley Wood January 14, 2020
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2018 Caitlin E. Cox September 04, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017
News Features Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions Michael O'Riordan May 08, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2016 Caitlin E. Cox September 01, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016